RSS0393 ointment placebo

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Reistone Biopharma Company Limited

Conditions

Plaque Psoriasis SubjectsPsoriatic Subjects

Phase 2

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

Not yet recruitingNCT06918743

Jiangsu HengRui Medicine Co., Ltd.Psoriatic Subjects

Start: 2025-04-30End: 2026-03-31Target: 147Updated: 2025-04-09

Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Not yet recruitingNCT07543224

Reistone Biopharma Company LimitedPlaque Psoriasis Subjects

Start: 2026-04-01End: 2027-12-01Target: 600Updated: 2026-04-21